Citable company snapshot
Bio-Techne's latest SEC-sourced 2026-03-31 period shows $311.42M in revenue and $51.05M in net income.
| Metric | Latest period | Latest value | Prior value | YoY |
|---|---|---|---|---|
| Revenue | Mar 31, 2026 | $311.42M | $295.88M | +5.3% |
| Gross Profit | Mar 31, 2026 | $208.29M | $191.28M | +8.9% |
| Operating Income | Mar 31, 2026 | $75.50M | $54.46M | +38.6% |
| Net Income | Mar 31, 2026 | $51.05M | $38.01M | +34.3% |
| Operating Cash Flow (computed) | Mar 31, 2026 | $86.66M | $82.41M | +5.2% |
| Free Cash Flow (computed) | Mar 31, 2026 | $77.58M | $76.49M | +1.4% |
Source: SEC EDGAR financial statements; period Mar 31, 2026; filed May 6, 2026; accession 0001104659-26-056302.
TECH company research is available with Aerarium Pro (CAD $10/mo). The five showcase tickers (TSLA, NVDA, AAPL, AMZN, PLTR) and the macro dashboard stay free. Already a subscriber? Sign in to pick up where you left off.